Beta Glucan And Chronic Kidney Disease (CKD)

Preview this chapter:

Beta Glucan And Chronic Kidney Disease (CKD), Page 1 of 1

< Previous page | Next page > /docserver/preview/fulltext/9789815039238/chapter-15-1.gif

<div&gt;Chronic kidney disease (CKD) is a global health problem that is associated&lt;/div&gt;<div&gt;with a high risk for cardiovascular morbidity and death. It is a clinical syndrome&lt;/div&gt;<div&gt;characterized by the progressive and irreversible loss of renal function. Dietary&lt;/div&gt;<div&gt;supplementation with grains containing high β-glucan fiber has been shown to&lt;/div&gt;<div&gt;attenuate the progression of CKD and vascular calcification in animal models. In this&lt;/div&gt;<div&gt;mini-review, the therapeutic effect of beta glucan on CKD was investigated. For this&lt;/div&gt;<div&gt;reason, many studies were examined and promising results were obtained for the use of&lt;/div&gt;<div&gt;beta glucan in the treating of CKD </div&gt;